Toxicodynamic analysis of cardiac effects induced by four cholinesterase inhibitors in rats

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 9, 1996, Pages 935-939

  Yamamoto, Koujirou ^a   Shimizu, Miho ^b   Ohtani, Hisakazu ^a   Hayashi, Masahiro ^b   Sawada, Yasufumi ^a,c   Iga, Tatsuji ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMBENONIUM; CHOLINESTERASE INHIBITOR; EDROPHONIUM; MUSCARINIC RECEPTOR; NEOSTIGMINE; PYRIDOSTIGMINE;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOTOXICITY; CHRONOTROPISM; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG POTENCY; DRUG SAFETY; ENZYME INHIBITION; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SYNAPSE; TACHYCARDIA;

EID: 0029905750     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb06006.x     Document Type: Article

References (11)

1. Backman, S. B., Bachoo, M., Polosa, C. (1993) Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine. J. Pharmacol. Exp. Ther. 265: 194-200
2. Brown, J. H., Wetzel, G. T., Dunlap, J. (1982) Activation and blockade of cardiac muscarinic receptors by endogenous acetylcholine and cholinesterase inhibitors. J. Pharmacokinet. Biopharm. 223: 20-24
3. Donati, F., Meistelman, C. (1991) A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs. J. Pharmacokinet. Biopharm. 19: 537-552
4. Gardner, R. M., Allen, D. O. (1977) The relationship between cyclic nucleotide levels and glycogen phosphorylase activity in isolated rat hearts perfused with epinephrine and acetylcholine. J. Pharmacol. Exp. Ther. 202: 346-353
5. Glavinovic, M. I., Min, J. C. L., Kapural, L., Donati, F., Bevan, D. R. (1992) Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis. J. Pharmacol. Exp. Ther. 265: 1181-1186
6. Kenakin, T. P., Beek, D. (1985) Self-cancellation of drug properties as a mode of organ selectivity: the antimuscarinic effects of ambenonium. J. Pharmacol. Exp. Ther. 232: 732-740
7. Kopman, A. F. (1989) Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency? Anesthesiology 70: 915-920
8. Min, J. C. L., Bekavac, I., Glavinovic, M. I., Donati, F., Bevan, D. R. (1992) Iontophoretic study of speed of action of various muscle relaxants. Anesthesiology 77: 351-356
9. Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., Ham., J. (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin. Pharmacol. Ther. 25: 358-371
10. Yamamoto, K., Sawada, Y., Iga, T. (1996) Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats. J. Pharmacokinet. Biopharm. In press
11. Yamaoka, K., Tanigawara, Y., Nakagawa, T., Uno, T. (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiodyn. 4: 879-885